In addition, several studies have reported that abnormal feeding regulation and weight gain in PWS is more related to changes in the ratio of des-acyl ghrelin to acyl ghrelin than total levels per se [277,278], suggesting that GOAT inhibitors may be of particular interest for the treatment of PWS. Here, MBOAT4 is linked to Prader-Willi syndrome.